vs
Privia Health Group, Inc.（PRVA）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是RBC Bearings INC的1.2倍（$541.2M vs $461.6M），RBC Bearings INC净利率更高（14.6% vs 1.7%，领先12.9%），Privia Health Group, Inc.同比增速更快（17.4% vs 17.0%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs 5.6%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
PRVA vs RBC — 直观对比
营收规模更大
PRVA
是对方的1.2倍
$461.6M
营收增速更快
PRVA
高出0.4%
17.0%
净利率更高
RBC
高出12.9%
1.7%
两年增速更快
PRVA
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $461.6M |
| 净利润 | $9.2M | $67.4M |
| 毛利率 | — | 44.3% |
| 营业利润率 | 2.1% | 22.3% |
| 净利率 | 1.7% | 14.6% |
| 营收同比 | 17.4% | 17.0% |
| 净利润同比 | 108.0% | 16.4% |
| 每股收益（稀释后） | $0.08 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVARBC
| Q4 25 | $541.2M | $461.6M | ||
| Q3 25 | $580.4M | $455.3M | ||
| Q2 25 | $521.2M | $436.0M | ||
| Q1 25 | $480.1M | $437.7M | ||
| Q4 24 | $460.9M | $394.4M | ||
| Q3 24 | $437.9M | $397.9M | ||
| Q2 24 | $422.3M | $406.3M | ||
| Q1 24 | $415.2M | $413.7M |
净利润PRVARBC
| Q4 25 | $9.2M | $67.4M | ||
| Q3 25 | $6.9M | $60.0M | ||
| Q2 25 | $2.7M | $68.5M | ||
| Q1 25 | $4.2M | $72.7M | ||
| Q4 24 | $4.4M | $57.9M | ||
| Q3 24 | $3.5M | $54.2M | ||
| Q2 24 | $3.5M | $61.4M | ||
| Q1 24 | $3.0M | — |
毛利率PRVARBC
| Q4 25 | — | 44.3% | ||
| Q3 25 | — | 44.1% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | 44.3% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 45.3% | ||
| Q1 24 | — | 43.1% |
营业利润率PRVARBC
| Q4 25 | 2.1% | 22.3% | ||
| Q3 25 | 2.5% | 21.5% | ||
| Q2 25 | 0.6% | 23.2% | ||
| Q1 25 | 1.1% | 23.0% | ||
| Q4 24 | 1.1% | 21.7% | ||
| Q3 24 | 1.3% | 21.6% | ||
| Q2 24 | 1.2% | 24.0% | ||
| Q1 24 | 0.2% | 22.8% |
净利率PRVARBC
| Q4 25 | 1.7% | 14.6% | ||
| Q3 25 | 1.2% | 13.2% | ||
| Q2 25 | 0.5% | 15.7% | ||
| Q1 25 | 0.9% | 16.6% | ||
| Q4 24 | 1.0% | 14.7% | ||
| Q3 24 | 0.8% | 13.6% | ||
| Q2 24 | 0.8% | 15.1% | ||
| Q1 24 | 0.7% | — |
每股收益（稀释后）PRVARBC
| Q4 25 | $0.08 | $2.13 | ||
| Q3 25 | $0.05 | $1.90 | ||
| Q2 25 | $0.02 | $2.17 | ||
| Q1 25 | $0.03 | $2.33 | ||
| Q4 24 | $0.03 | $1.82 | ||
| Q3 24 | $0.03 | $1.65 | ||
| Q2 24 | $0.03 | $1.90 | ||
| Q1 24 | $0.02 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | $107.6M |
| 总债务越低越好 | — | $990.2M |
| 股东权益账面价值 | $737.2M | $3.3B |
| 总资产 | $1.4B | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资PRVARBC
| Q4 25 | $479.7M | $107.6M | ||
| Q3 25 | $441.4M | $91.2M | ||
| Q2 25 | $390.1M | $132.9M | ||
| Q1 25 | $469.3M | $36.8M | ||
| Q4 24 | $491.1M | — | ||
| Q3 24 | $422.0M | — | ||
| Q2 24 | $387.4M | $76.8M | ||
| Q1 24 | $351.1M | $63.5M |
总债务PRVARBC
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益PRVARBC
| Q4 25 | $737.2M | $3.3B | ||
| Q3 25 | $709.1M | $3.2B | ||
| Q2 25 | $682.9M | $3.1B | ||
| Q1 25 | $659.4M | $3.0B | ||
| Q4 24 | $635.2M | $2.9B | ||
| Q3 24 | $614.9M | $2.9B | ||
| Q2 24 | $595.4M | $2.8B | ||
| Q1 24 | $576.8M | $2.8B |
总资产PRVARBC
| Q4 25 | $1.4B | $5.1B | ||
| Q3 25 | $1.4B | $5.1B | ||
| Q2 25 | $1.3B | $4.8B | ||
| Q1 25 | $1.2B | $4.7B | ||
| Q4 24 | $1.1B | $4.7B | ||
| Q3 24 | $1.1B | $4.7B | ||
| Q2 24 | $1.1B | $4.7B | ||
| Q1 24 | $1.0B | $4.7B |
负债/权益比PRVARBC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | — | $99.1M |
| 自由现金流率自由现金流/营收 | — | 21.5% |
| 资本支出强度资本支出/营收 | — | 5.0% |
| 现金转化率经营现金流/净利润 | 13.93× | 1.81× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRVARBC
| Q4 25 | $127.5M | $122.1M | ||
| Q3 25 | $52.0M | $88.4M | ||
| Q2 25 | $8.0M | $120.0M | ||
| Q1 25 | $-24.1M | — | ||
| Q4 24 | $74.8M | $84.0M | ||
| Q3 24 | $33.2M | — | ||
| Q2 24 | $34.5M | $97.4M | ||
| Q1 24 | $-33.1M | — |
自由现金流PRVARBC
| Q4 25 | — | $99.1M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | — | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | — | — |
自由现金流率PRVARBC
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 15.7% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | — |
资本支出强度PRVARBC
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | — |
现金转化率PRVARBC
| Q4 25 | 13.93× | 1.81× | ||
| Q3 25 | 7.58× | 1.47× | ||
| Q2 25 | 2.97× | 1.75× | ||
| Q1 25 | -5.70× | — | ||
| Q4 24 | 17.00× | 1.45× | ||
| Q3 24 | 9.38× | — | ||
| Q2 24 | 9.94× | 1.59× | ||
| Q1 24 | -11.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
